PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Iodine→

Iodine PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
7553-56-2
Molecular formula
I2
Molecular weight
253.8089 g/mol
Drug class
Halogen antiseptic and essential trace elementthyroid-hormone substrate
Mechanism of action
As an antiseptic, free iodine reacts with and oxidises microbial proteins, nucleotides and membrane components, producing broad antimicrobial activity. Physiologically, iodide is taken up by the thyroid and incorporated into thyroxine (T4) and triiodothyronine (T3).
Indications / reported uses
  • Topical antiseptic use in iodine solutions and iodophor preparations, according to formulation and route.
  • Prevention and treatment of iodine deficiency with appropriately formulated dietary or medicinal products.

Sources: https://www.cdc.gov/infection-control/hcp/disinfection-sterilization/chemical-disinfectants.html · https://ods.od.nih.gov/factsheets/Iodine-HealthProfessional/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Iodine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Iodine Permitted Daily Exposure (PDE) report (the Iodine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Iodine Occupational Exposure Limit (OEL) report (the Iodine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.